Free Trial

Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Teza Capital Management LLC

Azenta logo with Medical background

Teza Capital Management LLC lowered its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 80.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,036 shares of the company's stock after selling 24,926 shares during the period. Teza Capital Management LLC's holdings in Azenta were worth $302,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Picton Mahoney Asset Management increased its position in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after buying an additional 532 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of Azenta in the fourth quarter valued at about $40,000. Covestor Ltd increased its stake in shares of Azenta by 64.2% during the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after purchasing an additional 799 shares in the last quarter. KBC Group NV lifted its stake in Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares in the last quarter. Finally, Quarry LP purchased a new position in Azenta in the 4th quarter valued at about $110,000. 99.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Needham & Company LLC decreased their target price on Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th. TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th. Finally, Evercore ISI lifted their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th.

Read Our Latest Research Report on AZTA

Azenta Stock Down 3.7%

Shares of AZTA traded down $1.03 during midday trading on Monday, reaching $27.00. The company had a trading volume of 865,146 shares, compared to its average volume of 690,558. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $63.58. The firm has a 50 day simple moving average of $29.05 and a 200-day simple moving average of $40.94. The stock has a market cap of $1.24 billion, a PE ratio of -9.06 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. The business's revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.06 EPS. As a group, sell-side analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines